Boundless Bio
boundless was formed to deliver a new therapeutic approach for patients with amplified cancers by targeting the underlying biology mise boundless founded series a series series | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
13 of 51
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
August 2020
therapeutic approach to improve survival in preclinical model of | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
March 2023
an innovative enzyme approach to lowering | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
June 2020
therapeutic approach to improve survival in preclinical model of | Aeglea BioTherapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io